| scholarly article | Q13442814 |
| P819 | ADS bibcode | 2019NatCo..10.2757G |
| P356 | DOI | 10.1038/S41467-019-10688-X |
| P932 | PMC publication ID | 6588633 |
| P698 | PubMed publication ID | 31227697 |
| P50 | author | Ulf Smith | Q56809371 |
| P2093 | author name string | Birgit Gustafson | |
| Annika Nerstedt | |||
| P2860 | cites work | Functional genomics of the CDKN2A/B locus in cardiovascular and metabolic disease: what have we learned from GWASs? | Q38368484 |
| ZFP521 regulates murine hematopoietic stem cell function and facilitates MLL-AF9 leukemogenesis in mouse and human cells. | Q38700338 | ||
| Adipose tissue regulates insulin sensitivity: role of adipogenesis, de novo lipogenesis and novel lipids | Q38809397 | ||
| Physiological Aging: Links Among Adipose Tissue Dysfunction, Diabetes, and Frailty | Q39032248 | ||
| Plasminogen Activator Inhibitor-1 Is a Marker and a Mediator of Senescence | Q39344951 | ||
| Integrative genomic analysis implicates limited peripheral adipose storage capacity in the pathogenesis of human insulin resistance. | Q40476668 | ||
| The tumour suppressor CDKN2A/p16INK4a regulates adipogenesis and bone marrow-dependent development of perivascular adipose tissue | Q42649980 | ||
| Unmasking Transcriptional Heterogeneity in Senescent Cells | Q42777490 | ||
| DNA Damage and the Activation of the p53 Pathway Mediate Alterations in Metabolic and Secretory Functions of Adipocytes | Q42809189 | ||
| Increased fat cell size: a major phenotype of subcutaneous white adipose tissue in non-obese individuals with type 2 diabetes. | Q47344563 | ||
| BMP4 and BMP Antagonists Regulate Human White and Beige Adipogenesis | Q47757011 | ||
| Insulin action and age. European Group for the Study of Insulin Resistance (EGIR). | Q51028523 | ||
| Regulatory variants at KLF14 influence type 2 diabetes risk via a female-specific effect on adipocyte size and body composition | Q53697033 | ||
| A crucial role for adipose tissue p53 in the regulation of insulin resistance | Q84491291 | ||
| Family history of type 2 diabetes increases the risk of both obesity and its complications: is type 2 diabetes a disease of inappropriate lipid storage? | Q87415819 | ||
| Senolytics improve physical function and increase lifespan in old age | Q89486364 | ||
| Impaired Adipogenesis and Dysfunctional Adipose Tissue in Human Hypertrophic Obesity | Q90685537 | ||
| Targeting senescent cells alleviates obesity-induced metabolic dysfunction | Q92589039 | ||
| Cellular senescence in aging and age-related disease: from mechanisms to therapy | Q26773500 | ||
| Pathophysiology of Human Visceral Obesity: An Update | Q26864356 | ||
| Clearance of p16Ink4a-positive senescent cells delays ageing-associated disorders | Q28252088 | ||
| Dynamics of fat cell turnover in humans | Q29615688 | ||
| Adipocyte turnover: relevance to human adipose tissue morphology | Q33556451 | ||
| Transcriptional control of preadipocyte determination by Zfp423. | Q33753951 | ||
| Cellular senescence drives age-dependent hepatic steatosis. | Q33810220 | ||
| Genetic Predisposition for Type 2 Diabetes, but Not for Overweight/Obesity, Is Associated with a Restricted Adipogenesis | Q33885827 | ||
| Adipose-derived mesenchymal stromal/stem cells: An update on their phenotype in vivo and in vitro | Q34038832 | ||
| Cellular senescence: from physiology to pathology | Q34041305 | ||
| Direct transcriptional repression of Zfp423 by Zfp521 mediates a bone morphogenic protein-dependent osteoblast versus adipocyte lineage commitment switch | Q34056522 | ||
| Regulation of early adipose commitment by Zfp521. | Q34499279 | ||
| Targeting senescent cells enhances adipogenesis and metabolic function in old age | Q34505890 | ||
| Stable stem cell commitment to the adipocyte lineage by inhibition of DNA methylation: role of the BMP-4 gene. | Q35016478 | ||
| Mdm2 inhibitor Nutlin-3a induces p53-mediated apoptosis by transcription-dependent and transcription-independent mechanisms and may overcome Atm-mediated resistance to fludarabine in chronic lymphocytic leukemia | Q35849887 | ||
| WISP2 regulates preadipocyte commitment and PPARγ activation by BMP4. | Q36616934 | ||
| Restricted adipogenesis in hypertrophic obesity: the role of WISP2, WNT, and BMP4 | Q37110526 | ||
| Impaired preadipocyte differentiation in human abdominal obesity: role of Wnt, tumor necrosis factor-alpha, and inflammation | Q37236239 | ||
| Imaging mass spectrometry demonstrates age-related decline in human adipose plasticity | Q37677435 | ||
| Stromal cells from the adipose tissue-derived stromal vascular fraction and culture expanded adipose tissue-derived stromal/stem cells: a joint statement of the International Federation for Adipose Therapeutics and Science (IFATS) and the Internatio | Q37691742 | ||
| P433 | issue | 1 | |
| P921 | main subject | adipogenesis | Q2824461 |
| P304 | page(s) | 2757 | |
| P577 | publication date | 2019-06-21 | |
| P1433 | published in | Nature Communications | Q573880 |
| P1476 | title | Reduced subcutaneous adipogenesis in human hypertrophic obesity is linked to senescent precursor cells | |
| P478 | volume | 10 |
| Q96609566 | Adipose tissue morphology, imaging and metabolomics predicting cardiometabolic risk and family history of type 2 diabetes in non-obese men |
| Q104479851 | Age-associated telomere attrition in adipocyte progenitors predisposes to metabolic disease |
| Q98226258 | Fate of Adipose Progenitor Cells in Obesity-Related Chronic Inflammation |
| Q94522061 | Human pluripotent stem cell-based models suggest preadipocyte senescence as a possible cause of metabolic complications of Werner and Bloom Syndromes |
| Q98611605 | Markers of remodeling in subcutaneous adipose tissue are strongly associated with overweight and insulin sensitivity in healthy non-obese men |
| Q90393831 | Role of p53 in the Regulation of Cellular Senescence |
| Q101564351 | Sexual dimorphism in cardiometabolic health: the role of adipose tissue, muscle and liver |
| Q90246578 | The role of cellular senescence in ageing and endocrine disease |
Search more.